Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taussig Cancer Institute is the primary oncology treatment and research arm of the Cleveland Clinic, recognized as one of the leading cancer centers in the United States. The institute provides comprehensive, multidisciplinary care for all types of adult and pediatric cancers, integrating clinical practice with an extensive clinical trials program. Housed in a state-of-the-art facility in Cleveland, Ohio, it offers advanced services in medical oncology, radiation oncology, and blood and marrow transplantation. As a major academic research hub, Taussig participates in hundreds of clinical trials ranging from Phase 1 first-in-human studies to large-scale Phase 3 confirmatory trials. The institute is dedicated to advancing personalized medicine through genomic testing and innovative therapeutic modalities like CAR-T cell therapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Taussig Cancer Institute.